...
首页> 外文期刊>Stem cell research >Generation of the induced human pluripotent stem cell lines CSSi009-A from a patient with a GNB5 pathogenic variant, and CSSi010-A from a CRISPR/Cas9 engineered GNB5 knock-out human cell line
【24h】

Generation of the induced human pluripotent stem cell lines CSSi009-A from a patient with a GNB5 pathogenic variant, and CSSi010-A from a CRISPR/Cas9 engineered GNB5 knock-out human cell line

机译:从患者用GNB5致病变体的患者产生诱导的人多能干细胞系CSSI009-A,以及来自CRISPR / CAS9的CSSI010-A工程化GNB5敲除人细胞系

获取原文

摘要

GNB5 loss-of-function pathogenic variants cause IDDCA, a rare autosomal recessive human genetic disease characterized by infantile onset of intellectual disability, sinus bradycardia, hypotonia, visual abnormalities, and epilepsy. We generated human induced pluripotent stem cells (hiPSCs) from skin fibroblasts of a patient with the homozygous c.136delG frameshift variant, and a GNB5 knock-out (KO) line by CRISPR/Cas9 editing. hiPSCs express common pluripotency markers and differentiate into the three germ layers. These lines represent a powerful cellular model to study the molecular basis of GNB5-related disorders as well as offer an in vitro model for drug screening.
机译:GNB5丧失功能致病变体导致IDDCA,一种罕见的常染色体隐性人类遗传疾病,其特征在于智力发作,窦性病心动力,鼻窦癌,低呼吸道,视觉异常和癫痫。通过用纯合C.136delg架构变体和CRISPR / CAS9编辑,从患者的皮肤成纤维细胞和GNB5敲除(KO)线的皮肤成纤维细胞生成人诱导的多能干细胞(HIPSC)。 HIPSCS表达常见的多能性标记并分化为三个胚层。这些线代表了一种强大的蜂窝模型,用于研究GNB5相关疾病的分子基础,以及提供药物筛选的体外模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号